SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-155829
Filing Date
2016-12-19
Accepted
2016-12-19 14:30:37
Documents
1
Period of Report
2016-12-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7198
  Complete submission text file 0001209191-16-155829.txt   8554
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Issuer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
MILLER LLOYD I III (Reporting) CIK: 0000949119 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21214 | Film No.: 162058666